Digital Lifestyle Intervention for Lung Cancer Survivors
Recruiting · NCT05819346 · Interventional (participants receive a specific treatment) · Lead sponsor: Kai-Uwe Schmitt, PhD, MEng, ICID
View the official record on ClinicalTrials.gov →Interventions studied
Lifestyle
What this trial is about
The aim of this study is to assess the efficacy of a digital lifestyle intervention in non-small cell lung cancer (NSCLC) survivors on health-related quality of life (HRQoL) over three months.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age ≥ 18 years
- Diagnosis of non-small cell lung cancer (NSCLC)
- Estimated life expectancy of ≥ six months (judged by local investigators/responsible health professionals)
- Undergoing inpatient or outpatient rehabilitation OR completion of planned surgery, chemotherapy, or radiation therapy for NSCLC within the past 24 weeks
- Knowledge of German to understand study material and assessments
- Access to a cell phone or tablet
- Written informed consent
Exclusion criteria
- Inability to provide informed consent
- Inability to participate in the intervention because of physical, cognitive, or safety reasons (judged by local investigators/responsible health professionals)
Where it is running
4 locations listed.
- Klinik Barmelweid AG - Barmelweid, Switzerland
- Zürcher RehaZentren | Klinik Davos - Davos, Switzerland
- Berner Reha Zentrum AG - Heiligenschwendi, Switzerland
- Zürcher RehaZentren | Klinik Wald - Wald, Switzerland